What conditions can be treated with BMT?

BMT treats blood cancers (leukaemia, lymphoma, myeloma), bone marrow failure (aplastic anaemia), and genetic disorders including sickle cell disease and thalassaemia.

How long will I need to remain near the hospital after transplant?

For allogeneic transplants, patients typically need to stay near the transplant centre for about 100 days post-transplant for close monitoring of engraftment and graft-versus-host disease, per Cleveland Clinic; autologous transplant patients generally have a shorter required monitoring period. Your transplant team will confirm the exact timeline for your case.

Kudin Ciniki

Dashen Kashin Bango

Transplant

payments

Daga

$11,000

Har zuwa $80,000 ya danganta da cibiya

schedule

Tsawon lokaci na yau da kullum

30–60 days

Hada da gwaje-gwajen kafin tiyata

arrow_downwardlocal_hospital

Asibitocin hadin gwiwa

An duba su don bayanan sakamako da takardar shaida

Loading treatments…

Dashen Ƙashin Ƙuda/Sel Shina na Autologous da Allogeneic

Dashen ƙashin ƙuda (sel shina na haematopoietic) yana amfani da ko dai sel shina na majinyacin da kansa ko sel shina daga mai bayarwa. Wanne irin ne ya dace, in akwai, ana ƙaddara shi ta tawagar haematology da dashen bisa cutar da ke tattare, samuwar mai bayarwa, da lafiyar gaba ɗaya ta majinyaci — ba taɓa kai wa kanku hukunci ba.

Ma'auni	Autologous	Allogeneic
Tushen sel shina & amfani na yau da kullum	Yana amfani da sel shina na majinyacin da kansa da aka tattara kuma aka ajiye a baya; ana amfani da shi sau da yawa don yanayi kamar myeloma da yawa da wasu lymphoma, bisa ga Mayo Clinic da Cleveland Clinic.	Yana amfani da sel shina daga mai bayarwa mai dacewa (dan uwa, mai bayarwa da ba dangi ba, ko a wasu lokutan dan uwa mai dacewa sashi/haploidentical); ana amfani da shi ga leukemia, cututtukan gazawar ƙashin ƙuda, da wasu cututtukan kwayoyin halitta ciki har da cutar sickle cell, bisa ga Cleveland Clinic.
Tsarin shirye-shirye & bincike na mai bayarwa	Ana ba da chemotherapy na shirye-shirye (tare ko ba tare da radiation ba) kafin a mayar da sel shina na majinyacin da aka ajiye; babu bukatar tsarin daidaita mai bayarwa.	Yana buƙatar daidaiton nama (HLA) na mai bayarwa kafin shirye-shirye; tsarin shirye-shirye kuma yana nufin rage garkuwar jiki don hana ƙin sel na mai bayarwa, bisa ga Cleveland Clinic.
Haɗarin cutar graft-versus-host (GVHD)	Ba ta shafi — sel na majinyacin da kansa ba za su iya haifar da cutar graft-versus-host ba.	Babban haɗari na musamman ga dashen allogeneic, inda sel na garkuwar jiki na mai bayarwa ke yaƙi da naman mai karɓa; an ruwaito GVHD na dindindin a kusan kashi 30% zuwa 50% na masu karɓar allogeneic a cikin bincike da aka wallafa, bisa ga National Marrow Donor Program (NMDP)/Be The Match.
Zama a asibiti & lokacin sa ido	Zama a asibiti na farko yawanci ya fi guntu, tare da yawancin marasa lafiya suna warkewa a cikin kimanin watanni biyu, bisa ga Mayo Clinic.	Yawanci yana buƙatar zama a asibiti na dogon lokaci don shirye-shirye da sa ido, kuma ana ba da shawarar marasa lafiya su kasance kusa da cibiyar dashen na kwanaki 100 na farko bayan dashen, bisa ga Cleveland Clinic.
Jadawalin murmurewa gaba ɗaya	Yawancin marasa lafiya suna warkewa a cikin kimanin watanni biyu, bisa ga Mayo Clinic.	Cikakken murmurewa, ciki har da murmurewar garkuwar jiki, na iya ɗauka watanni da yawa zuwa fiye da shekara guda, bisa ga Mayo Clinic da Cleveland Clinic.

Tsarin: Mataki bayan Mataki

Bayanin da ke ƙasa yana nuna tsarin gama-gari na dashen ƙashin ƙuda/sel shina. Tawagar ku ta haematology da dashen za ta tabbatar da matakai na musamman da jadawali don yanayinku, wanda ya dogara da ganewar asali da irin dashen.

Bincike, rarrabuwar HLA & tattara sel shina ko bincike na mai bayarwa

Tawagar haematology da dashen suna bincika ganewar asali da lafiyar gaba ɗaya ta majinyaci; ga dashen autologous, ana tattara sel shina na majinyacin da kansa a ajiye tun da wuri, yayin da dashen allogeneic ke buƙatar rarrabuwar HLA da gano mai bayarwa mai dacewa isashe, bisa ga Cleveland Clinic.

Tsarin shirye-shirye

Ana ba da chemotherapy da/ko radiation don magance cutar da ke tattare da kuma yin sarari a ƙashin ƙuda ga sabbin sel shina; ga dashen allogeneic, shirye-shirye kuma yana rage garkuwar jiki don taimakawa hana ƙin. Wannan mataki yawanci yana buƙatar kimanin mako guda zuwa biyu na zama a asibiti, bisa ga Cleveland Clinic.

Zuba sel shina

Ana zuba sel shina ta hanyar catheter na jijiya ta tsakiya, kama da ƙarin jini; zubawar da kanta yawanci tana ɗaukar kimanin mintuna 30 zuwa 'yan sa'o'i, bisa ga Cleveland Clinic.

Haɗewar sel & sa ido sosai

Yawanci yana ɗaukar kimanin kwanaki 10 zuwa makonni biyu don sabbin sel shina su fara samar da sel na jini a ƙashin ƙuda (haɗewa); ƙidayar jini na ci gaba da kasancewa ƙasa sosai a wannan lokaci, don haka ana sa ido sosai a asibiti kan haɗarin kamuwa da cuta da zubar jini, bisa ga Mayo Clinic da Cleveland Clinic.

Jadawalin Murmurewa

Mint 30–sa'o'i

Zubawar sel shina da kanta yawanci tana ɗaukar kimanin mintuna 30 zuwa 'yan sa'o'i, kama da ƙarin jini, bisa ga Cleveland Clinic.

Kwana 10–mako 2

Haɗewar sel — sabbin sel shina su fara samar da sel na jini — yawanci tana ɗaukar kimanin kwanaki 10 zuwa makonni biyu; ƙidayar jini na ƙasa sosai a wannan lokaci, tare da haɗarin kamuwa da cuta da zubar jini mai girma, bisa ga Mayo Clinic da Cleveland Clinic.

~kwana 100

Ga dashen allogeneic, ana ba da shawarar marasa lafiya su kasance kusa da cibiyar dashen na kwanaki 100 na farko don sa ido sosai kan haɗewar sel da cutar graft-versus-host, bisa ga Cleveland Clinic.

Wata 2–shekara 1+

Yawancin marasa lafiya na dashen autologous suna warkewa a cikin kimanin watanni biyu, yayin da marasa lafiya na allogeneic na iya buƙatar watanni da yawa zuwa fiye da shekara guda don cikakken murmurewar garkuwar jiki; jadawali na musamman ya bambanta bisa cuta da irin dashen, bisa ga Mayo Clinic da Cleveland Clinic.

Tushen: Mayo Clinic; Cleveland Clinic. Murmurewa da sakamako na musamman sun bambanta kuma tawagar ku ta haematology da dashen ce ke jagoranta su.

⚠

Haɗari da Iyakoki da aka sani

Ƙidayar jini na ci gaba da kasancewa ƙasa sosai na kimanin makonni biyu bayan dashen, lokacin da marasa lafiya ke cikin haɗarin kamuwa da cuta da zubar jini mai girma, bisa ga Mayo Clinic.
Cutar graft-versus-host mai tsanani na iya shafar masu karɓar dashen allogeneic, yawanci farawa kwanaki 10 zuwa 90 bayan dashen; bayanan da aka wallafa sun ruwaito za ta iya faruwa a kusan kashi 50% na masu karɓar dashen daga mai bayarwa dan uwa mai dacewa da HLA, tare da manyan matakai da suka shafi masu bayarwa da ba su dace kusa ba, bisa ga Cleveland Clinic da National Marrow Donor Program (NMDP)/Be The Match.
Cutar graft-versus-host na dindindin, yawanci farawa kusan kwanaki 90 zuwa 600 bayan dashen, an ruwaito ta a kusan kashi 30% zuwa 50% na masu karɓar allogeneic a cikin bayanan da aka wallafa kuma na iya ci gaba na shekaru, bisa ga National Marrow Donor Program (NMDP)/Be The Match.
Cutar veno-occlusive (wanda ake kira sinusoidal obstruction syndrome), matsalar hanta da ke da alaƙa da tsarin shirye-shirye, an ruwaito ta a matakai daban-daban a cikin bincike-bincike — misali, matsakaicin kashi 2% zuwa 4% a wasu bincike na rukunin manya — matakin ya dogara sosai kan tsarin shirye-shirye da irin dashen, bisa ga bincike da aka bita da kuma na rijistar EBMT.
Kamar kowane dashe, kasawar sel su haɗe, ƙarancin jini, da sauran matsaloli sun yiwu; haɗarin gaba ɗaya ya dogara kan cutar da ke tattare, irin dashen, da shekaru da lafiyar majinyaci, bisa ga Mayo Clinic.

Tushen: Mayo Clinic; Cleveland Clinic; National Marrow Donor Program (NMDP)/Be The Match; bincike da aka bita da kuma na rijistar EBMT kan cutar graft-versus-host da cutar veno-occlusive. Babu wani tsari da ba shi da haɗari; tawagar dashen ku za ta duba yanayinku na musamman.

Hanyar Kula ta CureSureMedico

Bitar likita ta nesa

Raba ganewar asalinku, tarihin maganin da suka gabata, da sakamakon gwaje-gwaje, kuma ku sanar da mu ko akwai mai bayarwa mai yiwuwa ko riga an rarrabu HLA. Tawagarmu ta daidaitawa tana aika yanayinku ga tawagar haematology da dashen don kimantawa ta farko.

Daidaita mai bayarwa & haɗin gwiwar cibiya

Inda ake buƙatar dashen allogeneic, ana shirya rarrabuwar HLA da bincike na mai bayarwa ko kimanta lafiyar mai bayarwa; inda ake shirin dashen autologous, ana daidaita tattarawa da ajiyar sel shina tare da cibiyar da za ta karɓa.

Daidaita asibiti & kimantawa

Ana bayar da kimanin kudi mai haɗe wanda ya ƙunshi bincike kafin dashen, kimantawar mai bayarwa (idan an buƙata), tsarin shirye-shirye da tsarin dashen, da lokacin sa ido na farko kafin tafiya.

Dashen & murmurewa na farko

Ana daidaita tafiya, bincike na ƙarshe kafin dashen, tsarin shirye-shirye, zubar sel shina, da zamowar asibiti na farko har zuwa haɗewar sel tare da tawagar kula da ku a duk lokacin.

Ci gaba da kulawa bayan dawowa

Ana raba taƙaitaccen rahoton fitowa, tsarin magani, da jadawalin bin diddigi da likitan haematology na gida kafin ku dawo gida, tare da daidaitawa ta nesa da ake samu don ci gaba da bin diddigi da duk wata tambaya da za ta taso.

Kwatancen farashi na duniya — Dashen Kashin Bango

Matsakaicin farashi da aka tsara a fadin cibiyoyinmu na hadin gwiwa. Farashin karshe ya danganta da tsananin yanayi da asibitin da aka zaba.

Kasa	Matsakaicin farashi	idan aka kwatanta da mafi araha
🇮🇳 India New Delhi · Chennai · Bengaluru · Hyderabad · Mumbai · Kochi Mafi Kima✓ An Tabbatar	$18,000	—chevron_right
🇹🇷 Turkey Istanbul Kimantawa	$65,000	+261%chevron_right
🇹🇭 Thailand Bangkok · Phuket · Chiang Mai Kimantawa	$35,000	+94%chevron_right
🇺🇸 US Kimantawa	$577,000	+3106%
🇬🇧 GB Kimantawa	$80,000	+344%

Farashi kimantawa ne kuma yana bambanta bisa ga cikakkun bayanan aikin, asibiti, da tsananin yanayin likita. Nemi kimar musamman don al'amarinku.

Asibitocin hadin gwiwa

55 cibiyoyi

Duba dukkan asibitoci

Médica Sur

Asibiti

Mexico City, Mexico

Hospital Médica Sur cibiya ce ta uku mai nufin ɗaukaka a Tlalpan, Mexico City, an san ta a matsayin mafi kyawun asibiti a Mexico na shekaru shida a jere ta hanyar jerin Newsweek na Mafi Kyawun Asibitoci a Duniya (2026). Asibiti ita ce cibiya ta farko da kuma ɗaya a Latin Amurka da ta shiga Mayo Clinic Care Network — tare da ofishin Mayo Clinic mai keɓe a wurin tun 2018 — kuma ɗaya daga cikin asibitoci huɗu kawai da aka amince da JCI a Mexico. Cibiyoyin ƙwarewa sama da 35 sun haɗa dukan hanyoyin likitanci mafi rikitarwa: tiyata ta robot (Da Vinci X), radiosurgery ta Gamma Knife, dashen gaɓoɓi (hanyoyin sama da 150 tun 2002), tiyata ta bariatric, oncology, neurosurgery, nephrology, da kashi.

JCI

200+

Likitoci Kwararru

220+

Gadaje

Duba Bayani

Taoufik Hospital Group

Asibiti

Tunis, Tunisia

Taoufik Hospitals Group (THG) ita ce cibiyar sadarwar asibitoci ta farko mai wurare da yawa a Tunisia wacce ta kunshi dukkan fannonin likitanci da tiyata, an kafa ta a 2014 kuma ta bunkasa ta hanyar sayayya hudu na gaba da gaba wanda ya hada da Clinique Taoufik, Clinique Soukra, Clinique Ezzahra, da Clinique Hannibal a fadin Tunis. Kungiyar tana gudanar da gadaje 626, gadaje 100 na kulawa mai zurfi, da dakunan tiyata 30, tana rikodin sama da marasa lafiya 180,000 a duk shekara a fannoni 24 wadanda suka hada da zuciya, cutar kansa, tsarin jijiyoyi, mifupa, haihuwa, koda, da yara. THG tana da amincewar France Accreditation da takaddun shaida na Bureau Veritas, kuma tana bayar da ayyuka na musamman ga marasa lafiya na kasa da kasa ciki har da kimanta farashi cikin sa'o'i 48, masu kula da huldar marasa lafiya masu harsuna daban-daban da suke akwai a duk lokacin zama, da kuma cikakken lissafin kudi mai bayyana.

Cofrac

Bureau Veritas

200+

Likitoci Kwararru

626+

Gadaje

Duba Bayani

Amrita Hospital

Asibiti

Faridabad, India

Mafi babbar asibiti mai zaman kansa a Asiya — gadaje 2,600, dakunan tiyata 64, fannonin likitanci 81 a filin kadada 130 a Delhi NCR. An amince da NABH da NABL. Cibiyoyin kwarewa a oncology, tiyata ta zuciya, BMT, dashen gaɓoɓi, kimiyyar jijiya, da IVF.

NABH

NABL

800+

Likitoci Kwararru

2,600+

Gadaje

Duba Bayani

Medicana International İstanbul

Asibiti

Istanbul, Turkey

Medicana International Beylikdüzü, an kafa ta a 2007, asibiti ce mai fanni da yawa mai murabba'in mita 30,000 a gundumar Beylikdüzü ta Istanbul tare da sassan asibiti sama da 60. Cibiyar tana haɗa oncology ta zamani (MR-Linac, PET-CT, Linear Accelerator), kulawa ta zuciya tare da ICU na musamman na coronary da tiyata ta jijiyar zuciya, Cibiyar Dashen Ƙudan Ƙashi, dashen gaɓoɓi (hanta da koda), Cibiyar IVF/Assisted Reproduction, da dakin tiyata cikakke na neurosurgery — duka tare da goyon bayan tiyata ta robot Da Vinci da Cibiyar Majinyatan Kasa da Kasa mai harsuna da yawa.

200+

Likitoci Kwararru

200+

Gadaje

Duba Bayani